ACM Research, Inc.
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
On May 15, 2025, Sotheara Cheav, Senior Vice President, Manufacturing of ACM Research, Inc., adopted a Rule 10b5-1 trading arrangement (the “Cheav Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The Cheav Plan allows for the contemporaneous exercise of options and sale of up to 21,152 shares of Class A Common Stock, at specific market prices, commencing on August 15, 2025, and continuing until (i) all such options are exercised and the underlying shares are sold, (ii)May 16, 2026, or (iii) such date that the Cheav Plan is otherwise terminated according to its terms, whichever comes first.
On May 20, 2025, Jian Wang, Chief Executive Officer and President of ACM Shanghai, adopted a Rule 10b5-1 trading arrangement (the “Wang Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The Wang Plan allows for the contemporaneous exercise of options and sale of up to 90,000 shares of Class A Common Stock, at specific market prices, commencing on August 20, 2025, and continuing until (i) all such options are exercised and the underlying shares are sold, (ii)May 20, 2026, or (iii) such date that the Wang Plan is otherwise terminated according to its terms, whichever comes first.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.